阿里(BABA.US)美股創52周新低 遭拼多多搶佔中國第一電商地位
阿里巴巴(BABA.US)遭競爭對手Temu母公司拼多多(PDD.US)超越,搶佔中國最有價值電子商務公司,其後摩根士丹利因擔心阿里巴巴關鍵業務週轉速度放緩而下調其評級至「與大市同步」,拖累阿里巴巴美股股價週五(1日)下跌,創出52周新低。
阿里巴巴美股盤中曾跌逾3%,見一年新低。自阿里巴巴上個月公佈第二季業績,並取消分拆雲端業務的計劃後,該公司股價已累積下跌近17%。
拼多多週五同樣下跌,跌1%。但拼多多於公佈季度業績後,該股本週大幅上漲,週四收市市值接近1,960億美元,超過阿里巴巴1,904.5億美元的市值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.